Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United StatesResearch in context

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United StatesResearch in context

Summary: Background: Pulmonary fibrosis is characterized by lung parenchymal destruction and can increase morbidity and mortality. Pulmonary fibrosis commonly occurs following hospitalization for SARS-CoV-2 infection. As there are medications that modify pulmonary fibrosis risk, we investigated whet...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayodeji Adegunsoye (Author), Rachel Baccile (Author), Thomas J. Best (Author), Victoria Zaksas (Author), Hui Zhang (Author), Rasika Karnik (Author), Bhakti K. Patel (Author), Anthony E. Solomonides (Author), William F. Parker (Author), Julian Solway (Author)
Format: Book
Published: Elsevier, 2023-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items